Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance

Immune checkpoint blockade (ICB) has rapidly transformed the treatment paradigm for various cancer types. Multiple single or combinations of ICB treatments have been approved by the US Food and Drug Administration, providing more options for patients with advanced cancer. However, most patients coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaoting, Ni, Yanghong, Liang, Xiao, Lin, Yi, An, Biao, He, Xiang, Zhao, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520263/
https://www.ncbi.nlm.nih.gov/pubmed/36189283
http://dx.doi.org/10.3389/fimmu.2022.915094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520263/
https://www.ncbi.nlm.nih.gov/pubmed/36189283
http://dx.doi.org/10.3389/fimmu.2022.915094

Ejemplares similares